Medicinova (MNOV) Other Operating Expenses (2011 - 2026)

Medicinova (MNOV) posted quarterly Other Operating Expenses of $146985.0 for Q4 2025, up 27.51% quarter-over-quarter from $115272.0 in Q3 2025.

Medicinova (MNOV) Other Operating Expenses (2011 - 2026) Analysis & Trends

Medicinova (MNOV) has reported Other Operating Expenses for 9 consecutive years, with $146985.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Other Operating Expenses changed N/A year-over-year to $146985.0; the TTM figure through Dec 2025 stood at $378606.0 (changed N/A YoY), while the FY2025 annual figure was $378606.0, changed N/A from the prior year.
Other Operating Expenses rose to $146985.0 in Q4 2025 per MNOV's latest filing, from $115272.0 in the prior quarter.
Across five years, Other Operating Expenses topped out at $146985.0 in Q4 2025 and bottomed at $115272.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Medicinova	68.42 Mn	68.42 Mn	317,759.00

Download Data